These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2848517

  • 21. Effects of signalling transduction modulators on the transformed phenotypes in v-H-ras-transformed NIH 3T3 cells.
    Kuo ML, Kang JJ, Yang NC.
    Cancer Lett; 1993 Nov 01; 74(3):197-202. PubMed ID: 7513607
    [Abstract] [Full Text] [Related]

  • 22. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N, De Luca LM, Breitman TR.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):80-4. PubMed ID: 9345273
    [Abstract] [Full Text] [Related]

  • 23. Differential sensitivity to pertussis toxin of 3T3 cells transformed with different oncogenes.
    Rey I, Suarez H, Lavelle F, Tocque B.
    FEBS Lett; 1988 Sep 12; 237(1-2):203-7. PubMed ID: 3049149
    [Abstract] [Full Text] [Related]

  • 24. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
    Sugimoto Y, Ikawa Y, Nakauchi H.
    Cancer Res; 1991 Jan 01; 51(1):99-104. PubMed ID: 1670996
    [Abstract] [Full Text] [Related]

  • 25. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein.
    Constantinou A, Kiguchi K, Huberman E.
    Cancer Res; 1990 May 01; 50(9):2618-24. PubMed ID: 2158395
    [Abstract] [Full Text] [Related]

  • 26. Requirement of activated Cdc42-associated kinase for survival of v-Ras-transformed mammalian cells.
    Nur-E-Kamal A, Zhang A, Keenan SM, Wang XI, Seraj J, Satoh T, Meiners S, Welsh WJ.
    Mol Cancer Res; 2005 May 01; 3(5):297-305. PubMed ID: 15886301
    [Abstract] [Full Text] [Related]

  • 27. Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts.
    Janssen RA, Mier JW.
    Mol Biol Cell; 1997 May 01; 8(5):897-908. PubMed ID: 9168473
    [Abstract] [Full Text] [Related]

  • 28. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z.
    Cancer Res; 1992 Nov 15; 52(22):6200-8. PubMed ID: 1330289
    [Abstract] [Full Text] [Related]

  • 29. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells.
    Dean NM, Kanemitsu M, Boynton AL.
    Biochem Biophys Res Commun; 1989 Dec 15; 165(2):795-801. PubMed ID: 2532009
    [Abstract] [Full Text] [Related]

  • 30. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW, Santos-Moore A, Stevenson LE, Frackelton AR.
    Int J Cancer; 1996 Jan 17; 65(2):186-91. PubMed ID: 8567115
    [Abstract] [Full Text] [Related]

  • 31. Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
    Akiyama T, Ogawara H.
    Methods Enzymol; 1991 Jan 17; 201():362-70. PubMed ID: 1658553
    [No Abstract] [Full Text] [Related]

  • 32. Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta 1 occurs only in the presence of their normal counterparts.
    Silingardi P, Klein JL, Mesnil M, Yamasaki H.
    Carcinogenesis; 1994 Jun 17; 15(6):1181-5. PubMed ID: 8020153
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
    Omata-Yamada T, Yamada H, Lengyel P.
    J Cell Physiol; 1991 Nov 17; 149(2):214-21. PubMed ID: 1748716
    [Abstract] [Full Text] [Related]

  • 36. Regulation of mouse preimplantation development: inhibitory effect of genistein, an inhibitor of tyrosine protein phosphorylation, on cleavage of one-cell embryos.
    Besterman B, Schultz RM.
    J Exp Zool; 1990 Oct 17; 256(1):44-53. PubMed ID: 2401883
    [Abstract] [Full Text] [Related]

  • 37. Suppression of RAS and MOS transformation by radicicol.
    Zhao JF, Nakano H, Sharma S.
    Oncogene; 1995 Jul 06; 11(1):161-73. PubMed ID: 7624124
    [Abstract] [Full Text] [Related]

  • 38. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes.
    Kuo ML, Yang NC.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):767-75. PubMed ID: 7626110
    [Abstract] [Full Text] [Related]

  • 39. Differential effect of polyunsaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinase.
    Mollerup S, Haugen A.
    Br J Cancer; 1996 Aug 26; 74(4):613-8. PubMed ID: 8761379
    [Abstract] [Full Text] [Related]

  • 40. Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells.
    Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M, Umezawa K, Motoyoshi K.
    Leuk Res; 1991 Aug 26; 15(8):701-8. PubMed ID: 1895751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.